(Q47616807)

4 February 2018

title

Infliximab: Use in Inflammatory Bowel Disease (English)

1 reference

4 February 2018

inflammatory bowel diseases

main subject

0 references

inflammation

0 references

author name string

Win J Travassos

series ordinal

1

1 reference

4 February 2018

Adam S Cheifetz

series ordinal

2

1 reference

4 February 2018

publication date

1 June 2005

1 reference

4 February 2018

Current treatment options in gastroenterology

published in

1 reference

4 February 2018

volume

8

1 reference

4 February 2018

issue

3

1 reference

4 February 2018

page(s)

187-196

1 reference

4 February 2018

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

cites work

1 reference

12 December 2020

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians

1 reference

12 December 2020

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

12 December 2020

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

1 reference

12 December 2020

Inflammatory Bowel Disease

1 reference

12 December 2020

Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab

1 reference

12 December 2020

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1 reference

12 December 2020

Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study

1 reference

12 December 2020

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

1 reference

12 December 2020

High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy

1 reference

12 December 2020

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

12 December 2020

Medical management of severe ulcerative colitis

1 reference

12 December 2020

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease

1 reference

12 December 2020

The incidence and management of infusion reactions to infliximab: a large center experience

1 reference

12 December 2020

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis

1 reference

12 December 2020

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

12 December 2020

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

1 reference

12 December 2020

Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

1 reference

12 December 2020

Treatment of luminal and fistulizing Crohn's disease with infliximab

1 reference

12 December 2020

Predictors of response to infliximab in patients with Crohn's disease

1 reference

12 December 2020

Infliximab for refractory ulcerative colitis

1 reference

12 December 2020

Infliximab for patients with refractory ulcerative colitis

1 reference

12 December 2020

The cost of hospitalization in Crohn's disease

1 reference

12 December 2020

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo

1 reference

12 December 2020

Annual cost of care for Crohn's disease: a payor perspective.

1 reference

12 December 2020

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

12 December 2020

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

12 December 2020

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1 reference

12 December 2020

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

1 reference

12 December 2020

Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study

1 reference

12 December 2020

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease

1 reference

12 December 2020

Infliximab-induced lupus in Crohn's disease: a case report.

1 reference

12 December 2020

Optimizing anti-TNF treatment in inflammatory bowel disease

1 reference

12 December 2020

Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management

1 reference

12 December 2020

Review article: skin complications associated with inflammatory bowel disease

1 reference

12 December 2020

Tumour necrosis factor and Crohn's disease

1 reference

12 December 2020

Infliximab maintenance therapy for fistulizing Crohn's disease

1 reference

12 December 2020

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

12 December 2020

Novel biologics in inflammatory bowel disease

1 reference

12 December 2020

Cytokine-based therapies for Crohn's disease--new paradigms

1 reference

12 December 2020

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

1 reference

12 December 2020

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

1 reference

12 December 2020

10.1007/S11938-005-0011-2

Identifiers

DOI

1 reference

4 February 2018

release_ius4cidkmrhcpfzd7edfpjvqwe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ius4cidkmrhcpfzd7edfpjvqwe

24 November 2022

mapped directly with Wikidata item

1 reference

4 February 2018